Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02754336|
Recruitment Status : Completed
First Posted : April 28, 2016
Last Update Posted : April 28, 2016
|Condition or disease||Intervention/treatment||Phase|
|ADHD||Behavioral: Cogmed Robomemo, working memory training Behavioral: Othmer, neurofeedback||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study|
|Study Start Date :||October 2014|
|Actual Primary Completion Date :||June 2015|
|Actual Study Completion Date :||June 2015|
Active Comparator: Cogmed Robomemo, working memory training
Robomemo working memory training, 25 sessions with 8 verbal and non-verbal tasks per session.
Behavioral: Cogmed Robomemo, working memory training
Active Comparator: Othmer, neurofeedback
Othmer method neurofeedback, 25 sessions a 30 minutes.
Behavioral: Othmer, neurofeedback
- Neuropsychological tests [ Time Frame: 3-4 weeks after last training session ]Subtests from the NEPSY-II test battery
- Quantum EEG [ Time Frame: 3-4 weeks after last training session ]Electroencephalography (EEG) is the measurement of electrical patterns at the surface of the scalp which reflect cortical activity, and are commonly referred to as "brainwaves". Quantitative EEG (qEEG) is the analysis of the digitized EEG, and in lay terms this sometimes is also called "Brain Mapping"
- Questionaires [ Time Frame: 3-4 weeks after last training session ]5—15 (FTF) Parent Questionaire For Evaluation of Development and Behavior of 5 to 15-year-old children. Behavior Rating Inventory of Executive Function (BRIEF)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02754336
|Stavanger University Hospital|
|Stavanger, Norway, 4011|
|Principal Investigator:||Harald Beneventi, PhD||Helse Stavanger HF|